尼古丁胺胺单核酸 (NMN) 在2型糖尿病中通过脂肪组织的意想不到的影响起作用,而不是通过线粒体生物发生
Roua Gabriela Popescu1,2,3, Anca Dinischiotu1, Teodoru Soare4
1Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
International journal of molecular sciences
|March 13, 2024
概括
尼古丁胺胺单核酸 (NMN) 通过特定器官的机制改善葡萄糖的吸收. 这项研究揭示了NMN的存在.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 衰老的研究研究.
- 生物化学 生化学
背景情况:
- 尼古丁胺胺 mononucleotide (NMN) 是一个有前途的干预与年龄相关的疾病,如2型糖尿病.
- 以前的研究表明NMN在葡萄糖吸收中的作用,但机制仍然不清楚.
研究的目的:
- 为了确认NMN对葡萄糖吸收的影响.
- 调查NMN作用的潜在器官特异性机制.
- 探索NMN在代谢障碍中的治疗潜力.
主要方法:
- 在各种组织和细胞系中进行全面的蛋白质组分析.
- 使用腹腔内葡萄糖耐受性测试 (IPGTT) 测量葡萄糖吸收.
- 分析蛋白质合成,降解,信号通路和线粒体功能.
主要成果:
- 通过mTOR信号,NMN促进脂肪组织的生长,并在肌肉间脂肪组织中调节热生成的UCP1.
- NMN抑制肌肉和大脑中的线粒体生物发生,降低肝脏/肌肉中的结合酶体的调节,并降低蛋白质合成效率.
- NMN诱导大脑代谢重新连接,包括体的产生和OXPHOS和TCA循环组件的下调,模仿禁食效应.
结论:
- NMN表现出多方面的器官特异性影响,影响葡萄糖吸收和新陈代谢.
- 研究结果阐明了NMN的复杂机制,突出了它在治疗代谢障碍方面的潜力.
- 这项研究加深了对NMN在衰老和代谢疾病中的治疗应用的理解.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Role of Reduced Coenzymes NADH and FADH₂
11.5K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
11.5K


